TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02197897 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04693520 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT05653011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04167514 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT04643665 — Predictive Biomarker (PRD): PGD mRNA
Genes: PGD; PGDH
Study NCT01705587 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01682603 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04843839 — Predictive Biomarker (PRD): SLC4A11 mRNA
Genes: SLC4A11; BTR1
Study NCT01368185 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01280266 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT00899639 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00210379 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT02198651 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02380157 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02380157 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000433 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02719730 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02513771 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00479609 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT04198519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04475263 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03515304 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03515304 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00885885 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01026428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03965117 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00003067 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02981160 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04014192 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT00047307 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study NCT00091546 — Predictive Biomarker (PRD): BMPR2 mRNA
Genes: BMPR2; PPH1
Study NCT03973489 — Predictive Biomarker (PRD): TAAR1 mRNA
Genes: TAAR1; TA1; TAR1; TRAR1
Study NCT01690104 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT01690104 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03973203 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT01545024 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03153202 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT03124108 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT02199145 — Predictive Biomarker (PRD): PLA2R1 mRNA
Genes: PLA2R1; CLEC13C
Study NCT02199145 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00584051 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT02343419 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02343419 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02343419 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT03119246 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT00265967 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02380872 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT02601365 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01093573 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02177175 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00376246 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04402229 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02722772 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02722772 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT02722772 — Predictive Biomarker (PRD): MMP13 mRNA
Genes: MMP13
Study NCT02722772 — Safety Biomarker (SAF): Interleukin 1
Study NCT03957746 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03649178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01874873 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT01874873 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT03461185 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03461185 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03292393 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01106482 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02803619 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02803619 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06076226 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04245579 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03917082 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03917082 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00059280 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT01312831 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT01501669 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01028560 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00631917 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00814736 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT03819478 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00337454 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00337454 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT02062255 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study NCT03728335 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT02219711 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02219711 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT02219711 — Predictive Biomarker (PRD): MERTK mRNA
Genes: MERTK; MER
Study NCT02219711 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT02219711 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT02219711 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT02219711 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT02219711 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT02219711 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02219711 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT03393975 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT03393975 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT00997698 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02803658 — Pharmacodynamic Biomarker (PDY): Histone acetylation
Study NCT03720275 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT00004856 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03165864 — Predictive Biomarker (PRD): TMPRSS6 mRNA
Genes: TMPRSS6; UNQ354/PRO618
Study NCT02172651 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study NCT05347797 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02891954 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03258593 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT01674062 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03651245 — Predictive Biomarker (PRD): MAN2B1 mRNA
Genes: MAN2B1; LAMAN; MANB
Study NCT06571630 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04543253 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04543253 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT03785132 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01504542 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01974479 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00468546 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03295786 — Predictive Biomarker (PRD): CDNF mRNA
Genes: CDNF; ARMETL1
Study NCT03071302 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT03071302 — Predictive Biomarker (PRD): TIMP3 mRNA
Genes: TIMP3
Study NCT01732107 — Predictive Biomarker (PRD): FGFR3 mRNA
Genes: FGFR3; JTK4
Study NCT01732107 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT01855503 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01855503 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01197300 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01669512 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT03740165 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT03947385 — Predictive Biomarker (PRD): GNAQ mRNA
Genes: GNAQ; GAQ
Study NCT00374270 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01761890 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01761890 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT01630083 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT03120416 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00049283 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00049283 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02140554 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02140554 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01219855 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT03912987 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00345280 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01095965 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00717002 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04330339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04330339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04330339 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02018679 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT01793233 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04062565 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05274555 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT00776412 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT00693511 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01103115 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04352556 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00842465 — Predictive Biomarker (PRD): PRLR mRNA
Genes: PRLR
Study NCT01051115 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02674256 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT01608178 — Safety Biomarker (SAF): Succinate-semialdehyde dehydrogenase
Genes: ALDH5A1; SSADH
Study NCT01144195 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00638391 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01507103 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT01485198 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02773823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00057798 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT01993680 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT03222440 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02111967 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00204581 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04080531 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study NCT02118831 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02118831 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01366274 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01366274 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01366274 — Safety Biomarker (SAF): Interleukin 1
Study NCT01366274 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study NCT01366274 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03232892 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT01546987 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT03399747 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT04347278 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02132091 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SOD2 mRNA
Genes: SOD2
Study NCT02132091 — Predictive Biomarker (PRD): SIRT3 mRNA
Genes: SIRT3; SIR2L3
Study NCT02132091 — Predictive Biomarker (PRD): NRF1 mRNA
Genes: NRF1
Study NCT04525417 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04946162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01664104 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04297410 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04146051 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT02540642 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04769778 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT02356653 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05007860 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00606528 — Predictive Biomarker (PRD): FGL2 mRNA
Genes: FGL2
Study NCT01796470 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT01143675 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01872429 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00616291 — Predictive Biomarker (PRD): CTAG2 mRNA
Genes: CTAG2; ESO2; LAGE1
Study NCT04439357 — Predictive Biomarker (PRD): GNAQ mRNA
Genes: GNAQ; GAQ
Study NCT04439357 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT04439357 — Predictive Biomarker (PRD): MAP2K2 mRNA
Genes: MAP2K2; MEK2; MKK2; PRKMK2
Study NCT02767973 — Predictive Biomarker (PRD): GSTM1 mRNA
Genes: GSTM1; GST1
Study NCT00791869 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT04063462 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04063462 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01537094 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04101058 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT02231580 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01977976 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01977976 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study NCT01272258 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT00854464 — Predictive Biomarker (PRD): PNP mRNA
Genes: PNP; NP
Study NCT00854464 — Predictive Biomarker (PRD): GSTO2 mRNA
Genes: GSTO2
Study NCT00854464 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study NCT00854464 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study NCT00854464 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT00854464 — Predictive Biomarker (PRD): XRCC3 mRNA
Genes: XRCC3
Study NCT00854464 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02376036 — Predictive Biomarker (PRD): FCGR2B
Genes: CD32; CD32B; FcgammaRIIb; FcGRIIB
Study NCT02376036 — Predictive Biomarker (PRD): CD79B mRNA
Genes: CD79B; B29; IGB
Study NCT01817946 — Predictive Biomarker (PRD): MTM1 mRNA
Genes: MTM1; CG2
Study NCT01817946 — Predictive Biomarker (PRD): BIN1 mRNA
Genes: BIN1; AMPHL
Study NCT01817946 — Predictive Biomarker (PRD): DNM2 mRNA
Genes: DNM2; DYN2
Study NCT01817946 — Predictive Biomarker (PRD): RYR1 mRNA
Genes: RYR1; RYDR
Study NCT01817946 — Safety Biomarker (SAF): RYR1
Genes: RYR; PPP1R137
Study NCT04526457 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT03847818 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02532426 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study NCT00192595 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04003142 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01109121 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01807949 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01807949 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT01061320 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00877604 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02091960 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02091960 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT01275677 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03104985 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study NCT04138056 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00488995 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT00934011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00934011 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT00919360 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00919360 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02628951 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02628951 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00708448 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00708448 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00708448 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT03405753 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT03405753 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03405753 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01229202 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01229202 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01003964 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT06689709 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT02853084 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT05424705 — Predictive Biomarker (PRD): PLXNA2 mRNA
Genes: PLXNA2; KIAA0463; OCT; PLXN2; UNQ209/PRO235
Study NCT00630006 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00630006 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04018586 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01639690 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00907972 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00907972 — Surrogate Endpoint (SUR): Serum calcium